Pemphigus Vulgaris After COVID-19: a Case of Induced Autoimmunity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res. 2015;307(4):291–8. https://doi.org/10.1007/s00403-014-1531-1.
Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2020;11(8):762. https://doi.org/10.3390/v11080762.
Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020;14(2):126–35. https://doi.org/10.1007/s11684-020-0767-8.
Spuntarelli V, Luciani M, Bentivegna E, Marini V, Falangone F, Conforti G, et al. COVID-19: is it just a lung disease? A case-based review. SN Compr Clin Med. 2020:1–6. https://doi.org/10.1007/s42399-020-00418-6.
de Medeiros VLS, Silva LFT. Follow-up of skin lesions during the evolution of COVID-19: a case report. Arch Dermatol Res. 2020;14:1–4. https://doi.org/10.1007/s00403-020-02091-0.
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–7. https://doi.org/10.1111/bjd.19163.
Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 40(10):1539–54. https://doi.org/10.1007/s00296-020-04639-9.
Vojdani A. A potential link between environmental triggers and autoimmunity. Autoimmune Dis. 2014;2014:437231–18. https://doi.org/10.1155/2014/437231.
Powell AM, Black MM. Epitope spreading: protection from pathogens, but propagation of autoimmunity? Clin Exp Dermatol. 2001;26(5):427–33. https://doi.org/10.1046/j.1365-2230.2001.00852.x.
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–6. https://doi.org/10.1056/NEJMc2009191.
Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. https://doi.org/10.1212/NXI.0000000000000785.
Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204–7. https://doi.org/10.1111/jns.12382.
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094. https://doi.org/10.1136/bmj.m2094.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–8. https://doi.org/10.1016/S0140-6736(20)31103-X.
Agarwal S, Agrawal DK. Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol. 2017;13(3):247–58. https://doi.org/10.1080/1744666X.2017.1232165.
Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391–405. https://doi.org/10.1038/s41584-020-0426-0.
Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with coronavirus disease 2019? J Eur Acad Dermatol Venereol. 2020;34(6):e246–7. https://doi.org/10.1111/jdv.16471.
Sanchez A, Sohier P, Benghanem S, L’Honneur AS, Rozenberg F, Dupin N, et al. Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection. JAMA Dermatol. 2020;156(7):819–20. https://doi.org/10.1001/jamadermatol.2020.1704.
Mahajan K, Relhan V, Relhan AK, Garg VK. Pityriasis rosea: an update on etiopathogenesis and management of difficult aspects. Indian J Dermatol. 2016;61(4):375–84. https://doi.org/10.4103/0019-5154.185699.
Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61(2):303–18. https://doi.org/10.1016/j.jaad.2008.07.045.
Brunasso AMG, Castellaneta M, Pontali E, Raggi F, Massone C. Follow-up of skin lesions during COVID-19: a description of a DRESS case. Arch Dermatol Res. 2021;6:1–4. https://doi.org/10.1007/s00403-020-02171-1.
Goon AT, Tay YK, Tan SH. Pemphigus vulgaris following varicella infection. Clin Exp Dermatol. 2001;26(8):661–3. https://doi.org/10.1046/j.1365-2230.2001.00912.
Didona D, Di Zenzo G. Humoral epitope spreading in autoimmune bullous diseases. Front Immunol. 2018;9:779. https://doi.org/10.3389/fimmu.2018.00779.
Machado ARDSR, La Serra L, Turatti A, Machado AM, Roselino AM. Herpes simplex virus 1 and cytomegalovirus are associated with pemphigus vulgaris but not with pemphigus foliaceus disease. Exp Dermatol. 2017;26(10):966–8. https://doi.org/10.1111/exd.13342.
Maruta CW, Miyamoto D, Aoki V, Carvalho RGR, Cunha BM, Santi CG. Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview. An Bras Dermatol. 2019;94(4):388–98. https://doi.org/10.1590/abd1806-4841.20199165.
Chen L, Yang B, Fan J, Yang K, Liu H, Wu G. Peripheral T-cell lymphoma complicated by immunoglobulin A pemphigus: a case report and literature review. Oncol Lett. 2014;8(1):62–6. https://doi.org/10.3892/ol.2014.2088.